抗感染症薬市場：タイプ別、投与経路別、流通チャネル別、地域別、2025-2033年

抗感染症薬市場の世界市場規模は2024年に1,388億米ドルに達しました。今後、IMARC Groupは、2033年には1,800億米ドルに達し、2025～2033年の成長率（CAGR）は2.93%になると予測しています。

抗感染症薬は、感染症の拡大を抑制したり、感染因子を完全に死滅させたりすることで、感染症に作用する医薬品です。これらの医薬品には、抗生物質、抗ウイルス薬、抗真菌薬、抗マラリア薬、駆虫薬、抗原虫薬などが含まれます。これらの薬は一般的に経口、非経口、局所投与されます。肺炎や結核を含む軽度の感染症の治療に広く使用されています。また、帝王切開や人工関節置換術など、重症感染のリスクが高い日常的な処置や手術の際にも使用されます。

抗感染症薬市場の動向：

世界の抗感染症薬市場の主な原動力は、世界中で感染症が増加していることです。抗感染症薬は、ウイルス、細菌、寄生虫、真菌を含む感染症の治療に使用されます。さらに、天然物、クオラムセンシング阻害剤、バイオフィルム破壊剤、ガリウムベースの薬剤、シクロデキストリン阻害剤、光ベースの抗菌剤など、さまざまな戦略を用いて製剤化された新規薬剤の開発が、市場開拓に弾みをつけています。これに伴い、幹細胞や臓器オンチップ（OOC）技術など、創薬手順における最新の技術革新が創薬試験プロセスを強化し、市場に明るい展望をもたらしています。さらに、アスペルギルス症、侵襲性カンジダ症、粘菌症などのCOVID-19疾患や誘発感染症の出現による製品採用の増加が、市場の成長を強化しています。これに加えて、規制当局によって承認される新しい抗感染症薬の数が増加していることも、成長を促進する要因として作用しています。さらに、有利な政府政策の実施、革新的な新薬開発への投資の増加、感染症に対する個人の意識の高まり、医療インフラの急速な改善などが、今後数年間の市場成長を後押しすると予想されます。

本レポートで扱う主な質問

• 2024年の世界の抗感染症薬市場の市場規模は？
• 2025-2033年における世界の抗感染症薬市場の予想成長率は？
• 世界の抗感染症薬市場を牽引する主要因は何か？
• 世界の抗感染症薬市場に対するCOVID-19の影響は？
• 世界の抗感染症薬市場のタイプ別内訳は？
• 世界の抗感染症薬市場の投与経路別の内訳は？
• 世界の抗感染症薬市場の販売チャネル別内訳は？
• 世界の抗感染症薬市場における主要地域は？
• 世界の抗感染症薬市場における主要プレイヤー／企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査の目的
• ステークホルダー
• データソース
  • 一次情報
  • 二次情報
• 市場推定
  • ボトムアップアプローチ
  • トップダウンアプローチ
• 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

• 概要
• 主要業界動向

第5章 世界の抗感染症薬市場

• 市場概要
• 市場実績
• COVID-19の影響
• 市場予測

第6章 市場内訳：タイプ別

• 抗菌
• 抗真菌
• 抗ウィルス

第7章 市場内訳：投与経路別

• 局所
• 経口
• 静脈内（IV）
• その他

第8章 市場内訳：流通チャネル別

• 病院薬局
• 小売薬局
• 専門薬局
• オンラインストア
• その他

第9章 市場内訳：地域別

• 北米
  • 米国
  • カナダ
• アジア太平洋地域
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア
  • インドネシア
  • その他
• 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • ロシア
  • その他
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他
• 中東・アフリカ
  • 市場内訳：国別

第10章 SWOT分析

• 概要
• 強み
• 弱み
• 機会
• 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

• 概要
• 買い手の交渉力
• 供給企業の交渉力
• 競合の程度
• 新規参入業者の脅威
• 代替品の脅威

第13章 価格分析

第14章 競合情勢

• 市場構造
• 主要企業
• 主要企業のプロファイル
  • Abbott Laboratories
  • Cipla Health Ltd.（Cipla Limited）
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline plc
  • Glenmark Pharmaceuticals Limited
  • Johnson & Johnson
  • Lupin Limited
  • Sandoz AG（Novartis AG）
  • Sun Pharmaceutical Industries Limited

List of Figures

• Figure 1: Global: Anti-infectives Market: Major Drivers and Challenges
• Figure 2: Global: Anti-infectives Market: Sales Value (in Billion USD), 2019-2024
• Figure 3: Global: Anti-infectives Market Forecast: Sales Value (in Billion USD), 2025-2033
• Figure 4: Global: Anti-infectives Market: Breakup by Type (in %), 2024
• Figure 5: Global: Anti-infectives Market: Breakup by Route of Administration (in %), 2024
• Figure 6: Global: Anti-infectives Market: Breakup by Distribution Channel (in %), 2024
• Figure 7: Global: Anti-infectives Market: Breakup by Region (in %), 2024
• Figure 8: Global: Anti-infectives (Antibacterial) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 9: Global: Anti-infectives (Antibacterial) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 10: Global: Anti-infectives (Antifungal) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 11: Global: Anti-infectives (Antifungal) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 12: Global: Anti-infectives (Antiviral) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 13: Global: Anti-infectives (Antiviral) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 14: Global: Anti-infectives (Topical) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 15: Global: Anti-infectives (Topical) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 16: Global: Anti-infectives (Oral) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 17: Global: Anti-infectives (Oral) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 18: Global: Anti-infectives (Intravenous (IV)) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 19: Global: Anti-infectives (Intravenous (IV)) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 20: Global: Anti-infectives (Others) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 21: Global: Anti-infectives (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 22: Global: Anti-infectives (Hospital Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 23: Global: Anti-infectives (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 24: Global: Anti-infectives (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 25: Global: Anti-infectives (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 26: Global: Anti-infectives (Speciality Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 27: Global: Anti-infectives (Speciality Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 28: Global: Anti-infectives (Online Stores) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 29: Global: Anti-infectives (Online Stores) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 30: Global: Anti-infectives (Other Distribution Channels) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 31: Global: Anti-infectives (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 32: North America: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
• Figure 33: North America: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 34: United States: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
• Figure 35: United States: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 36: Canada: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
• Figure 37: Canada: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 38: Asia-Pacific: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
• Figure 39: Asia-Pacific: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 40: China: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
• Figure 41: China: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 42: Japan: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
• Figure 43: Japan: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 44: India: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
• Figure 45: India: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 46: South Korea: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
• Figure 47: South Korea: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 48: Australia: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
• Figure 49: Australia: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 50: Indonesia: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
• Figure 51: Indonesia: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 52: Others: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
• Figure 53: Others: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 54: Europe: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
• Figure 55: Europe: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 56: Germany: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
• Figure 57: Germany: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 58: France: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
• Figure 59: France: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 60: United Kingdom: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
• Figure 61: United Kingdom: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 62: Italy: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
• Figure 63: Italy: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 64: Spain: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
• Figure 65: Spain: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 66: Russia: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
• Figure 67: Russia: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 68: Others: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
• Figure 69: Others: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 70: Latin America: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
• Figure 71: Latin America: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 72: Brazil: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
• Figure 73: Brazil: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 74: Mexico: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
• Figure 75: Mexico: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 76: Others: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
• Figure 77: Others: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 78: Middle East and Africa: Anti-infectives Market: Sales Value (in Million USD), 2019 & 2024
• Figure 79: Middle East and Africa: Anti-infectives Market: Breakup by Country (in %), 2024
• Figure 80: Middle East and Africa: Anti-infectives Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 81: Global: Anti-infectives Industry: SWOT Analysis
• Figure 82: Global: Anti-infectives Industry: Value Chain Analysis
• Figure 83: Global: Anti-infectives Industry: Porter's Five Forces Analysis

List of Tables

• Table 1: Global: Anti-infectives Market: Key Industry Highlights, 2024 and 2033
• Table 2: Global: Anti-infectives Market Forecast: Breakup by Type (in Million USD), 2025-2033
• Table 3: Global: Anti-infectives Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
• Table 4: Global: Anti-infectives Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
• Table 5: Global: Anti-infectives Market Forecast: Breakup by Region (in Million USD), 2025-2033
• Table 6: Global: Anti-infectives Market: Competitive Structure
• Table 7: Global: Anti-infectives Market: Key Players

The global anti-infectives market size reached USD 138.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 180.0 Billion by 2033, exhibiting a growth rate (CAGR) of 2.93% during 2025-2033.

Anti-infectives are medicines that act against infections, either by inhibiting the spread or killing the infectious agent outright. These medicines include antibiotics, antivirals, antifungals, antimalarials, anthelmintics, and antiprotozoals. They are generally administered through oral, parenteral, and topical routes. They are widely used to treat minor infectious diseases, including pneumonia and tuberculosis. Apart from this, anti-infectives are also utilized during routine procedures and surgeries, such as cesarian section and joint replacement, which are associated with a high risk of severe infection.

Anti-infectives Market Trends:

The global anti-infectives market is primarily driven by rising incidences of infectious diseases across the globe. Anti-Infinitives are used to treat infections, including viruses, bacteria, parasites, and fungi. Additionally, the development of novel drugs that are formulated using different strategies, such as natural products, quorum sensing inhibitors, biofilm disruptors, gallium-based drugs, cyclodextrin inhibitors, and light-based antimicrobials, are providing an impetus to the market growth. In line with this, the latest innovations in drug discovery procedures, such as stem cells and organ-on-chip (OOC) technologies, to enhance drug trial processes are creating a positive outlook for the market. Furthermore, the increasing product adoption due to the advent of the COVID-19 disease and induced infections, such as aspergillosis, invasive candidiasis, and mucormycosis, is strengthening the growth of the market. Besides this, the increasing number of new anti-infective drugs being approved by the regulatory authorities is acting as another growth-inducing factor. Moreover, the implementation of favorable government policies, rising investments in developing new and innovative drugs, increasing awareness among individuals about infectious diseases, and rapidly improving healthcare infrastructure are anticipated to impel the growth of the market in the coming years.

Key Market Segmentation:

Breakup by Type:

• Antibacterial
• Antifungal
• Antiviral

Breakup by Route of Administration:

• Topical
• Oral
• Intravenous (IV)
• Others

Breakup by Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Speciality Pharmacies
• Online Stores
• Others

Breakup by Region:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Cipla Health Ltd. (Cipla Limited), F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Glenmark Pharmaceuticals Limited, Johnson & Johnson, Lupin Limited, Sandoz AG (Novartis AG) and Sun Pharmaceutical Industries Limited.

Key Questions Answered in This Report

• 1.What was the size of the global anti-infectives market in 2024?
• 2.What is the expected growth rate of the global anti-infectives market during 2025-2033?
• 3.What are the key factors driving the global anti-infectives market?
• 4.What has been the impact of COVID-19 on the global anti-infectives market?
• 5.What is the breakup of the global anti-infectives market based on the type?
• 6.What is the breakup of the global anti-infectives market based on the route of administration?
• 7.What is the breakup of the global anti-infectives market based on distribution channel?
• 8.What are the key regions in the global anti-infectives market?
• 9.Who are the key players/companies in the global anti-infectives market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Anti-infectives Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Type

• 6.1 Antibacterial
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Antifungal
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Antiviral
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast

7 Market Breakup by Route of Administration

• 7.1 Topical
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Oral
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Intravenous (IV)
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Others
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast

8 Market Breakup by Distribution Channel

• 8.1 Hospital Pharmacies
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Retail Pharmacies
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Speciality Pharmacies
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Online Stores
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast
• 8.5 Others
  • 8.5.1 Market Trends
  • 8.5.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Abbott Laboratories
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
    • 14.3.1.3 Financials
    • 14.3.1.4 SWOT Analysis
  • 14.3.2 Cipla Health Ltd. (Cipla Limited)
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
  • 14.3.3 F. Hoffmann-La Roche AG
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
    • 14.3.3.3 Financials
  • 14.3.4 GlaxoSmithKline plc
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
    • 14.3.4.3 Financials
    • 14.3.4.4 SWOT Analysis
  • 14.3.5 Glenmark Pharmaceuticals Limited
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
    • 14.3.5.3 Financials
    • 14.3.5.4 SWOT Analysis
  • 14.3.6 Johnson & Johnson
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
    • 14.3.6.3 Financials
    • 14.3.6.4 SWOT Analysis
  • 14.3.7 Lupin Limited
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
    • 14.3.7.3 Financials
    • 14.3.7.4 SWOT Analysis
  • 14.3.8 Sandoz AG (Novartis AG)
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
  • 14.3.9 Sun Pharmaceutical Industries Limited
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
    • 14.3.9.3 Financials
    • 14.3.9.4 SWOT Analysis